A Phase II Multi-center, Open Label, Randomized Study to Assess Safety and Efficacy of Two Different Schedules of Oral LDE225 in Adult Patients With Relapsed/Refractory or Untreated Elderly Patients With Acute Leukemia

Cancer type: Leukemia

Phase: II

Principal Investigator: Gjertsen Bjørn Tore

Country: NO

Keywords: Norway, Bergen

Status: Completed

Link to